US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,839.79

+0.73010.04%

Number of Gainers:15

Number of Losers:2

Number of Flat:1

PE:- -

High:1,850.99

Open:1,846.61

Low:1,837.29

Close:1,839.06

Volume:122.50M

Turnover:6.20B

Market Cap:1.50T

Float Cap:1.48T

Loading ...

Gilead: Strategic Arcellx Acquisition and Anito-cel Pipeline Strength Underpin Buy Rating and $162 Target

Pfizer's Oral Cancer Medication Braftovi Receives FDA Approval for Colorectal Cancer Treatment

How JNJ, TEM, and LLY Used AI to Redefine Healthcare Compounding

Vir Biotechnology’s Call Highlights Astellas Deal, VIR-5500 Momentum

Class Action Lawsuit Targets Inovio Pharmaceuticals

NYSE Most Active Issues

Arvinas FY 2025 net loss narrows to USD 80.8 million (59.4%)

Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors

BUZZ-Vir Biotech slips after unveiling $200 mln stock offering plans

Merck FY 2025 Gardasil/Gardasil 9 sales fall 39% to USD 5.2 billion

Pfizer initiated with an Underperform at RBC Capital

Vir Biotechnology Announces Proposed Public Offering of Common Stock

THOMSON REUTERS

Pfizer Gets Full FDA Approval for Braftovi Combination for Colon Cancer Treatment

MT Newswires Live

Wrongful Death Case Tests Abbott’s FreeStyle Libre 3 Risk Oversight

Simply Wall St.

U.S. FDA Grants Full Approval to Pfizer’s Braftovi Combination Regimen in First-Line Metastatic Colorectal Cancer

THOMSON REUTERS

BRIEF-FDA Grants Traditional Approval To Encorafenib For Metastatic Colorectal Cancer With Braf V600e Mutation

FDA: Grants Traditional Approval to Encorafenib for Metastatic Colorectal Cancer With a Braf V600e Mutation

THOMSON REUTERS

Vir Biotechnology Up Nearly 34%, on Pace for Largest Percent Increase Since January 2025 -- Data Talk

Class Action Lawsuit Targets Lakeland Industries Inc

Vir Biotechnology price target raised to $18 from $14 at Needham

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4568/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1839.7878,"timestamp":1771966799999,"preClose":1839.0577,"halted":0,"volume":122503869,"delay":0,"changeRate":0.000397,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":0.730103,"latestTime":"02-24 16:00:00 EST","open":1846.6068,"high":1850.9868,"low":1837.2947,"amount":6204851618.701993,"amplitude":0.007445,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1772029800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.577425,"peRate":26.929153,"turnoverRate":0.008851,"increases":15,"decrements":2,"flats":1,"marketCap":1504648829859.75,"floatMarketCap":1480544666595.75},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1850.9868,"amplitude":0.007445,"preClose":1839.0577,"low":1837.2947,"pbRate":"4.577425","latestPrice":1839.7878,"volume":122503869,"delay":0,"open":1846.6068,"prevYearClose":1637.1339,"prevWeekClose":1820.3057,"prevMonthClose":1721.4615,"prevQuarterClose":1637.1339,"fiveDayClose":1838.9281,"twentyDayClose":1701.1533,"sixtyDayClose":1658.3433,"secType":"PLATE","market":"US","turnoverRate":0.008851,"peRate":26.929153,"marketCap":1504648829859.75,"floatMarketCap":1480544666595.75,"timestamp":1771966799999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":15,"down":2,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2614888220","title":"Gilead: Strategic Arcellx Acquisition and Anito-cel Pipeline Strength Underpin Buy Rating and $162 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2614888220","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614888220?lang=en_us&edition=fundamental","pubTime":"2026-02-25 18:06","pubTimestamp":1772013999,"startTime":"0","endTime":"0","summary":"Analyst Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Gilead Sciences and keeping the price target at $162.00. Tazeen Ahm...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/gilead-strategic-arcellx-acquisition-and-anito-cel-pipeline-strength-underpin-buy-rating-and-162-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/gilead-strategic-arcellx-acquisition-and-anito-cel-pipeline-strength-underpin-buy-rating-and-162-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SG9999015945.SGD","LU1037948897.HKD","SG9999015978.USD","LU1430594728.SGD","LU2089984988.USD","LU0106831901.USD","LU0170899867.USD","LU0640476718.USD","LU0965509283.SGD","LU1496350502.SGD","LU2087621335.USD","LU0648001328.SGD","BK4583","LU0203345920.USD","LU0314106906.USD","LU0868494617.USD","BAC","LU2129689605.HKD","LU0098860793.USD","BK4532","LU1894683348.USD","BK4578","LU0130102774.USD","LU0477156797.USD","SG9999015952.SGD","BK4568","LU0114720955.EUR","LU0234570918.USD","LU1791807156.HKD","LU0477156953.USD","LU0889565916.HKD","LU1674673428.USD","LU1267930227.SGD","LU0256863811.USD","BK4550","LU1366192091.USD","LU0306806265.USD","LU1496350171.SGD","BK4534","LU1585245621.USD","LU1883839398.USD","LU0882574055.USD","GILD","LU0070302665.USD","LU0208291251.USD","LU1880398471.USD","IE0001KFT4U8.USD","SG9999015986.USD","LU0149725797.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"1199514190","title":"Pfizer's Oral Cancer Medication Braftovi Receives FDA Approval for Colorectal Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1199514190","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199514190?lang=en_us&edition=fundamental","pubTime":"2026-02-25 11:18","pubTimestamp":1771989530,"startTime":"0","endTime":"0","summary":"The U.S. Food and Drug Administration (FDA) has granted approval for the first-line combination therapy of the oral anticancer drug Braftovi, developed by Pfizer in collaboration with Japan's Ono...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","SG9999001176.SGD","BK4588","SG9999002232.USD","IE00B19Z3581.USD","LU0234572021.USD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU0868494617.USD","LU1894683264.USD","BK4533","LU0306807586.USD","SG9999013999.USD","BK4568","SG9999003800.SGD","LU0058720904.USD","LU0456855351.SGD","SG9999001176.USD","LU1883839398.USD","PFE","LU0306806265.USD","BK4585","LU1894683348.USD","SG9999002224.SGD","LU0321505439.SGD","BK4534","BK4599","SG9999011175.SGD","IE000M9KFDE8.USD","LU0321505868.SGD","LU0122379950.USD","IE00BLSP4452.SGD","BK4550","LU1057294990.SGD","LU0225284248.USD","LU0985481810.HKD","LU1066053197.SGD","BK4007","IE00BBT3K403.USD","BK4592","LU0170899867.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","BK4581","LU0225771236.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"2614720826","title":"How JNJ, TEM, and LLY Used AI to Redefine Healthcare Compounding","url":"https://stock-news.laohu8.com/highlight/detail?id=2614720826","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614720826?lang=en_us&edition=fundamental","pubTime":"2026-02-25 09:06","pubTimestamp":1771981560,"startTime":"0","endTime":"0","summary":"Artificial intelligence (AI) is no longer a futuristic concept in healthcare — it is rapidly becoming a core engine of innovation across diagnostic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/how-jnj-tem-and-lly-used-ai-to-redefine-healthcare-compounding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/how-jnj-tem-and-lly-used-ai-to-redefine-healthcare-compounding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4550","LU1059921491.USD","IE00BK4W5M84.HKD","BK4533","BK4588","LU1914381329.SGD","LU2505996509.AUD","LU0795875086.SGD","LU2552382132.HKD","LU2265009873.SGD","LU0109391861.USD","LU2360106947.USD","LU1066051225.USD","LU2552382215.SGD","IE00BDGV0183.EUR","LU2271345857.HKD","IE00BBT3K403.USD","LU0029874061.USD","LU1804176565.USD","LU0471298777.SGD","IE00BLSP4239.USD","LU0471298694.HKD","LU1917777945.USD","LU2430703178.SGD","IE00B3PB1722.GBP","LU1032955483.USD","IE0002141913.USD","LU2213496289.HKD","LU0289739699.SGD","LU0689472784.USD","SG9999014880.SGD","LU1035775433.USD","IE00B19Z3581.USD","LU2168564222.USD","IE00BVYPNW00.USD","LU0094547139.USD","IE00BFXG1179.USD","LU0114720955.EUR","SG9999017495.SGD","BK4611","LU2491050154.USD","LU2756315664.SGD","IE0034235303.USD","LU2505996681.GBP","IE00BFSS7M15.SGD","IE00BJJMRY28.SGD","LU0708995401.HKD","IE00BZ1G4Q59.USD","LU0345770308.USD","LU0061475181.USD","BK4023","LU0345769128.USD","IE00BKVL7J92.USD","LU0689626769.HKD","BK4585","LU1868837300.USD","LU1868836914.USD","LU0889565916.HKD","LU0109394709.USD","IE00B7SZLL34.SGD","IE0005OL40V9.USD","LU0912757837.SGD","LU2089283258.USD","LU2324357040.USD","LABU","LU1868837136.USD","LU2089984988.USD","LU1267930813.SGD","LU2750360997.AUD","SG9999014914.USD","BK4137","LU2592432038.USD","LU2264538146.SGD","LU1244550577.SGD","LU1989771016.USD","LU0203202063.USD","LU1861559042.SGD","LU1064131342.USD","LU0096364046.USD","SGXZ57979304.SGD","LU1069344957.HKD","LU2023251221.USD","IE00B775H168.HKD","LU2106854487.HKD","BK4592","LU0345769631.USD","LU1861558580.USD","LU0266013472.USD","LU2211815571.USD","LU1718418525.SGD","LU1732799900.SGD","LU0432979614.USD","IE00BVYPNV92.GBP","IE00B1BXHZ80.USD","LU0158827948.USD","LU2129689514.USD","LU2750360641.GBP","LU2357305700.SGD","LU0672654240.SGD","LU1551013425.SGD","LU0820561909.HKD","LU2237443382.USD","TEMT","LU1127390331.HKD","IE00B4R5TH58.HKD","LU1366192091.USD","LU0316494557.USD","SG9999018865.SGD","SG9999014898.SGD","LU0006306889.USD","IE00B3T34201.USD","LU0882574055.USD","BK4599","LU1162221912.USD","LU0323591593.USD","LU0320765646.SGD","LU1506573853.SGD","LU1061106388.HKD","LU1032466523.USD","IE00BN8TJ469.HKD","SG9999015945.SGD","IE00B4JS1V06.HKD","SG9999001440.SGD","LU2129689605.HKD","LU0256863902.USD","IE00BK4W5L77.USD","ELIS","SG9999013999.USD","IE0004445015.USD","ELIL","SGXZ31699556.SGD","IE0004445239.USD","IE00BGHQF631.EUR","LU1551013342.USD","LU1778281490.HKD","LU0345770993.USD","LU2468319806.SGD","LU0820561818.USD","LU2023250504.SGD","LU2430703251.USD","LU0198837287.USD","LU0354030438.USD","LU1291159041.SGD","LU1720051017.SGD","LU1323610961.USD","SG9999001176.USD","LU1196500208.SGD","LU2347655156.SGD","XBI","BK4007","LU2237443622.USD","LU1720051108.HKD","LU0234572021.USD","LU2028103732.USD","LU0203345920.USD","SGXZ81514606.USD","LU1674673691.USD","IE00BWXC8680.SGD","LU2168563687.JPY","LU2087625088.SGD","LU1929549753.HKD","LU2168564495.EUR","LU2456880835.USD","LU0234570918.USD","LU0889566641.SGD","LU0320765992.SGD","LU0882574139.USD","LU0128526141.USD","LU1623119135.USD","LU1066053197.SGD","LU0353189680.USD","LU0070217475.USD","LU0823434740.USD","JNJ","LU0786609619.USD","IE00B42XCP33.USD","LU0256863811.USD","LU2756315318.SGD","LU1244550494.USD","LU1093756168.USD","LU2111349929.HKD","SG9999018857.SGD","LU2112291526.USD","LU2361044949.HKD","IE00BJJMRZ35.SGD","BK4121","LU1629891620.HKD","LU1145028129.USD","LU0964807845.USD","LU2129689431.USD","LU2552382058.USD","IE00BLSP4452.SGD","BK4504","LU2237443978.SGD","LU2471134879.HKD","LU2430703095.HKD","LU1868836591.USD","LU0122379950.USD","BK4528","LU1221951129.SGD","BK4559","LU2168564065.EUR","LU1868836757.USD","LU1496350502.SGD","LU0124676726.USD","LU0640476718.USD","TEM","LU0820562030.AUD","BK4587","LU2237443549.SGD","IE00B19Z3B42.SGD","LU1074936037.SGD","BK4534","LU0985320562.USD","LU1244550221.USD","LU2602419157.SGD","LU1974910355.USD","IE0009355771.USD","LU1267930730.SGD","IE000M9KFDE8.USD","LU1261432733.SGD","LU0792757196.USD","LU0079474960.USD","LU1894683348.USD","LU1814569148.SGD","LU2063271972.USD","SG9999002224.SGD","AIYY","LU0943347566.SGD","LU2746668461.USD","LU2471134796.USD","IE0001KFT4U8.USD","LU0466842654.USD","LU0210536198.USD","IE00BFSS8Q28.SGD","LLYX","LU0098860793.USD","LU1232071149.USD","IE00BJJMRX11.SGD","LU2237443465.HKD","LU0683600562.USD","BK4516","LU1674673428.USD","LU0787776722.HKD","LU0823416689.USD","LU1066051498.USD","LU2133065610.SGD","LU0353189763.USD","LU1712237335.SGD","LU0106261372.USD","LU1430594728.SGD","LLII","LU0225283273.USD","LU2089284900.SGD","LU2471134523.USD","LU0354030511.USD","BK4551","LU2491050071.SGD","SGXZ99366536.SGD","IE00BKPKM429.USD","SG9999001176.SGD","LU0823434583.USD","LU1894683264.USD","LU1548497426.USD","LU1585245621.USD","LLY","LU2361044865.SGD","LU2168564149.EUR","SG9999015986.USD","LU1983299246.USD","LU0417517546.SGD","LU2462157665.USD","LU1935042991.SGD","LU0456855351.SGD","LU0320765059.SGD","LU0385154629.USD","IE00BKDWB100.SGD","IE00BSNM7G36.USD","IE00B2B36J28.USD","LU1221951046.USD","IE00BFTCPJ56.SGD","LU0203347892.USD","LU2461242641.AUD","LU0158827781.USD","LU2023250330.USD","LU2896262040.SGD","LU0795875169.SGD","SG9999015978.USD","LU1057294990.SGD","BK4568","LU1732800096.USD","IE00B7KXQ091.USD","IE00BJT1NW94.SGD","GB00BDT5M118.USD","BK4581","BK4532","SG9999002232.USD","IE00BJLML261.HKD","LU2237443895.HKD","LU0238689110.USD","LU0058720904.USD","BK4613","LU2417539215.USD","BK4543","SGXZ51526630.SGD","LU1093756325.SGD","LU2471134952.CNY","SG9999014906.USD","LU0203201768.USD","LU2237438978.USD","LU2236285917.USD","LU1280957306.USD","LLYZ","LU1988902786.USD","LU2361045086.USD","LU1066051811.HKD","LU0097036916.USD","IE00B1XK9C88.USD","SG9999015952.SGD","LU2108987350.USD","IE0002270589.USD","LU1023059063.AUD","LU2746668974.SGD","LU2491049909.HKD","IE00BN29S564.USD"],"gpt_icon":0},{"id":"2614722367","title":"Vir Biotechnology’s Call Highlights Astellas Deal, VIR-5500 Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2614722367","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614722367?lang=en_us&edition=fundamental","pubTime":"2026-02-25 08:11","pubTimestamp":1771978287,"startTime":"0","endTime":"0","summary":"Vir Biotechnology, Inc. (($VIR)) has held its Q4 earnings call. Read on for the main highlights of the call. Vir Biotechnology’s latest earnings ca...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vir-biotechnologys-call-highlights-astellas-deal-vir-5500-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vir-biotechnologys-call-highlights-astellas-deal-vir-5500-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VIR","BK4535","BK4585","BK4568","BK4139"],"gpt_icon":0},{"id":"2614472928","title":"Class Action Lawsuit Targets Inovio Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2614472928","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614472928?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:58","pubTimestamp":1771973880,"startTime":"0","endTime":"0","summary":"A securities class action lawsuit has been filed against Inovio Pharmaceuticals Inc. in the U.S. District Court for the Eastern District of Pennsylvania on behalf of investors who bought or acquired the company’s securities between Oct. 10, 2023 and Dec. 26, 2025. The suit alleges the company made false or misleading statements and omissions about manufacturing deficiencies tied to its CELLECTRA device and the regulatory prospects for INO-3107, including the likelihood and basis for an accelerated approval filing. Investors have until April 7, 2026 to seek appointment as lead plaintiff.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL1DZL9f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INO","SG9999014021.USD","BK4583","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","LU0314104364.USD","LU2210150020.SGD","IE00B64PRP62.GBP","BK4568","LU2210149790.SGD","SG9999014039.USD","BK4588","IE00BKPKM429.USD","BK4139","SG9999014013.SGD","LU2095319765.USD","NDAQ","SG9999014005.SGD","BK4585","BK4112"],"gpt_icon":0},{"id":"2614729661","title":"NYSE Most Active Issues","url":"https://stock-news.laohu8.com/highlight/detail?id=2614729661","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614729661?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:43","pubTimestamp":1771972980,"startTime":"0","endTime":"0","summary":"Blue Owl Capital             OWL    65,787,061     10.73     0.29      2.78. Hims & Hers Health          HIMS    63,794,531     15.46    -0.05     -0.32. Bank of America              BAC    53,050,945     50.41    -0.66     -1.29. Nu Holdings Cl A              NU    49,687,066     16.53     0.34      2.10. Novo Nordisk ADR             NVO    43,800,414     38.59    -1.04     -2.62. Itau Unibanco ADR           ITUB    29,765,557      9.33     0.16      1.74. Petroleo Brasileiro ADR      PBR    26,646,509     16.54     0.40      2.48","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4553","NYSE","LU0683600562.USD","LU1093756168.USD","BK4547","SGXZ57979304.SGD","LU1883839398.USD","LU0128525689.USD","SG9999001176.SGD","LU2129689605.HKD","LU1861559042.SGD","LU0320765489.SGD","LU0985481810.HKD","LU1506573853.SGD","PATH","IE00BBT3K403.USD","IE0034235188.USD","LU1035773651.USD","LU1280957306.USD","LU2133065610.SGD","IE00B19Z3581.USD","BK4592","LU1162221912.USD","LU1880398471.USD","LU1861558580.USD","BK4604","LU2129689431.USD","BK4007","LU1201861249.SGD","BAC","PFE","LU1496350171.SGD","LU1668664300.SGD","LU0289739699.SGD","BK4551","BK4539","LU0154236417.USD","BK4504","BK4588","NVOX","LU0234572021.USD","LU1363072403.SGD","BK4568","SG9999013999.USD","LU0321505868.SGD","PATX","NVOH","LU2265009873.SGD","LU0314106906.USD"],"gpt_icon":1},{"id":"2614726142","title":"Arvinas FY 2025 net loss narrows to USD 80.8 million (59.4%)","url":"https://stock-news.laohu8.com/highlight/detail?id=2614726142","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614726142?lang=en_us&edition=fundamental","pubTime":"2026-02-25 06:20","pubTimestamp":1771971617,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arvinas Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDLyNsf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","LU1894683348.USD","LU0306807586.USD","IE00B19Z3B42.SGD","LU1066051498.USD","ARVN","IE0002270589.USD","SG9999013999.USD","IE000M9KFDE8.USD","BK4588","BK4585","BK4592","LU1057294990.SGD","BK4550","LU1066053197.SGD","SG9999002232.USD","LU0170899867.USD","BK4533","LU1023059063.AUD","IE00BLSP4452.SGD","LU0321505868.SGD","LU0122379950.USD","BK4568","IE00BLSP4239.USD","LU0289739699.SGD","LU1894683264.USD","LU0225771236.USD","LU0306806265.USD","LU0321505439.SGD","SG9999011175.SGD","IE00B19Z3581.USD","LU0456855351.SGD","LU1883839398.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4007","SG9999002224.SGD","IE00BBT3K403.USD","BK4599","BK4581","LU0868494617.USD","SG9999001176.USD","LU0058720904.USD","LU0234572021.USD","BK4534","SG9999003800.SGD","SG9999001176.SGD"],"gpt_icon":0},{"id":"2614408723","title":"Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2614408723","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614408723?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:35","pubTimestamp":1771968900,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 1.46% to $147.64 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.77% to 6,890.07 and the Dow Jones Industrial Average  rising 0.76% to 49,174.50.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 6.14% below its 52-week high of $157.29, which the company reached on February 11th.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 0.71% to $246.28, Pfizer Inc.  rose 0.30% to $27.14, and Abbott Laboratories  fell 0.62% to $114.58.Trading volume  eclipsed its 50-day average volume of 7.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled February 24, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones News","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","LU0234572021.USD","LU2592432038.USD","LU1935042991.SGD","IE00BN8TJ469.HKD","LU2505996681.GBP","BK4559","LU2129689431.USD","SG9999015945.SGD","LU0795875169.SGD","LU1032955483.USD","IE0002270589.USD","LU0320765646.SGD","IE0034235303.USD","IE00B4R5TH58.HKD","LU1989763690.USD","SG9999004303.SGD","LU1267930813.SGD","LU1037948541.HKD","BK4568","LU1983299246.USD","LU1571399168.USD","BK4588","LU1674673428.USD","SG9999015978.USD","LU1929549753.HKD","LU1732800096.USD","SG9999015952.SGD","LU1061106388.HKD","LU0170899867.USD","BK4566","LU2471134879.HKD","LU1778281490.HKD","LU1883839398.USD","LU1244550577.SGD","LU0965509101.SGD","LU1732799900.SGD","IE000M9KFDE8.USD","LU0912757837.SGD","LU2602419157.SGD","IE00BVYPNW00.USD","LU0234570918.USD","SG9999002232.USD","LU2750360641.GBP","LU0456855351.SGD","LU0289739699.SGD","BK4585","IE00B2B36J28.USD","LU1162221912.USD","LU1430594728.SGD","LU2468319806.SGD","LU0792757196.USD","SGXZ23171101.USD","BK4504","LU0058720904.USD","LU1221951129.SGD","SG9999001176.SGD","BK4534","LU0889566641.SGD","BK4581","BK4599","LU1721429402.USD","LU0321505868.SGD","BK4007","LU0345770308.USD","SG9999011175.SGD","LU1585245621.USD","IE00B3PB1722.GBP","LU1989763427.SGD","IE00B7SZLL34.SGD","BK4583","LU0965509010.AUD","LU2430703251.USD","BK4550","LU0345769128.USD","GILD","IE00B19Z3581.USD","IE00BBT3K403.USD","LU0122379950.USD","LU0795875086.SGD","LU1066051225.USD","LU1221951046.USD","LU2133065610.SGD","LU0868494617.USD","LU1066051811.HKD","LU1074936037.SGD","LU1496350502.SGD","LU0203345920.USD","SG9999001176.USD","LU0098860793.USD","LU0787776722.HKD","IE00B19Z3B42.SGD","LU2430703178.SGD","SG9999003800.SGD","IE00BFTCPJ56.SGD","IE00BKVL7J92.USD","LU2129689605.HKD","LU2471134523.USD","LU0882574055.USD","LU2347655156.SGD","LU2129689514.USD","LU1066053197.SGD","LU0203347892.USD","SGXZ41872573.SGD","LU0321505439.SGD","LU0985320562.USD","BK4533","LU0345770993.USD","SG9999001440.SGD","LU0114720955.EUR","LU0306807586.USD","SGXZ57979304.SGD","LU0683600562.USD","LU0689626769.HKD","LU0320765992.SGD","BK4578","LU0965509283.SGD","SG9999015986.USD","LU0070217475.USD","LU0432979614.USD","LU1023059063.AUD","LU1691799644.USD","LU1914381329.SGD","IE00BFXG1179.USD","LU1244550494.USD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0109394709.USD","LU0823416689.USD","LU0306806265.USD","IE00BGHQF631.EUR","LU2324357040.USD","LU0225284248.USD","LU2237957902.USD","LU1261432733.SGD","IE0002141913.USD","LU1718418525.SGD","IE0009355771.USD","SG9999013999.USD","BK4592","LU2505996509.AUD","BK4139","BK4532","IE00B42XCP33.USD","LU1032466523.USD","LU2089984988.USD","IE0001KFT4U8.USD","LU1894683264.USD","LU0889565916.HKD","IE00BVYPNV92.GBP","LU0124676726.USD","LU1244550221.USD","LU1506573853.SGD","LU1059921491.USD","LU1839511570.USD","IE00BSNM7G36.USD","LU2471134952.CNY","LU1721429741.USD","LU2087621335.USD","LU1066051498.USD","LU1894683348.USD","LU1037948897.HKD","LU2112291526.USD","IE00BDGV0183.EUR","LU0266013472.USD","LU2211815571.USD","LU2750360997.AUD","BK4082","LU0965508806.USD","LU1196500208.SGD","LU0861579265.USD","IE00BLSP4239.USD","LU1057294990.SGD","LU2471134796.USD","LU0640476718.USD","SG9999002224.SGD","LU0345769631.USD","LU0225771236.USD","LU0985481810.HKD","LU0466842654.USD","IE00B3T34201.USD","IE00BLSP4452.SGD","LU2237957811.SGD","IE00BZ1G4Q59.USD","LU2430703095.HKD","LU1674673691.USD","IE00B1BXHZ80.USD"],"gpt_icon":0},{"id":"2614648723","title":"BUZZ-Vir Biotech slips after unveiling $200 mln stock offering plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2614648723","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614648723?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:28","pubTimestamp":1771968532,"startTime":"0","endTime":"0","summary":"** Shares of Vir Biotechnology VIR.O slip 5.2% to $9 post-market as it looks to raise equity after its stock soared in regular session. ** VIR shares finished up 27.7% at $9.49 on Tues after co posted Q4 results beat and said plans to develop and commercialize its prostate cancer experimental drug with Japan's Astellas 4503.T. ** San Francisco, California-based VIR announces $200 mln stock offering after the bell. ** Goldman Sachs, Leerink, Evercore and Barclays joint bookrunners** Co has ~139.5 mln shares outstanding for about $1.3 bln market cap. ** All 10 analysts are bullish on VIR; median PT $17, per LSEG data","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nL6N3ZK1GZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2265009873.SGD","IE00BFXG1179.USD","LU1791807156.HKD","LU2471134952.CNY","LU0106831901.USD","IE00B19Z3B42.SGD","IE0004086264.USD","LU1868837300.USD","BK4504","IE0002270589.USD","LU2237443382.USD","IE00BSNM7G36.USD","BK4516","EVR","LU1868836591.USD","LU2237438978.USD","LU2237443622.USD","BK4568","LU0061475181.USD","BK4533","LU0251142724.SGD","LU0742534661.SGD","IE0034235188.USD","LU2471134879.HKD","LU0345770993.USD","BK4552","LU1868836914.USD","BK4535","LU2471134523.USD","LU1804176565.USD","LU1894683264.USD","BK4139","LU0251131958.USD","LU1668664300.SGD","IE00B19Z3581.USD","GSX","VIR","IE0004091025.USD","LU1868836757.USD","LU2237443978.SGD","BK4127","LU0345770308.USD","LU2750360641.GBP","LU1894683348.USD","LU0048573561.USD","LU2237443895.HKD","LU2750360997.AUD","BK4588","LU2237443465.HKD"],"gpt_icon":0},{"id":"2614723586","title":"Merck FY 2025 Gardasil/Gardasil 9 sales fall 39% to USD 5.2 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2614723586","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614723586?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:23","pubTimestamp":1771968196,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck & Co. Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL3JZtyd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001176.USD","IE00BFXG1179.USD","IE00B1BXHZ80.USD","IE00B7SZLL34.SGD","LU1035773651.USD","LU1162221912.USD","BK4532","LU1069347547.HKD","LU2125154778.USD","LU1066053197.SGD","LU1571399168.USD","LU0203345920.USD","LU1941712264.USD","IE00BDGV0183.EUR","BK4585","IE00BVYPNV92.GBP","LU1674673428.USD","LU0070217475.USD","LU0114720955.EUR","LU0265550946.USD","LU0640476718.USD","LU2106854487.HKD","SG9999015358.SGD","LU1934455863.HKD","LU0266013472.USD","LU2361044949.HKD","LU1941712348.USD","LU1066051225.USD","LU2023250504.SGD","LU1430594728.SGD","LU1929549753.HKD","LU1934455277.USD","LU0965509101.SGD","LU1989771016.USD","LU1221951129.SGD","LU0106261372.USD","LU1074936037.SGD","LU2505996681.GBP","IE00BFTCPJ56.SGD","LU1059921491.USD","LU1032466523.USD","LU0792757196.USD","LU0234570918.USD","LU0345770308.USD","LU0795875086.SGD","IE00BZ1G4Q59.USD","IE0002141913.USD","LU1778281490.HKD","SG9999015341.SGD","LU1934455194.USD","LU1061106388.HKD","SG9999002224.SGD","LU0208291251.USD","IE00BJJMRZ35.SGD","LU0795875169.SGD","IE0009355771.USD","LU1244550494.USD","LU1989772840.SGD","LU2089984988.USD","LU0345769631.USD","LU1674673691.USD","LU1732799900.SGD","LU1732800096.USD","LU2129689431.USD","IE00B42XCP33.USD","SG9999001440.SGD","LU0265550359.USD","LU0466842654.USD","LU0985320562.USD","LU1983299246.USD","IE0002270589.USD","LU1699723380.USD","LU0683600562.USD","LU1267930813.SGD","LU2361044865.SGD","LU1037948897.HKD","LU0432979614.USD","SG9999002232.USD","LU1894683348.USD","LU0070302665.USD","LU0203347892.USD","LU2430703178.SGD","LU2461242641.AUD","LU2125154935.USD","SG9999013999.USD","LU0648001328.SGD","LU1116320737.USD","LU0320765646.SGD","BK4559","LU0234572021.USD","LU2468319806.SGD","LU0320765489.SGD","LU1585245621.USD","LU0130517989.USD","LU1244550577.SGD","LU2471134879.HKD","LU0289739699.SGD","IE0001KFT4U8.USD","LU1023059063.AUD","LU1244550221.USD","LU0477156953.USD","LU2129689605.HKD","LU1506573853.SGD","LU0980610538.SGD","LU1974910355.USD","LU2360032135.SGD","IE00BSNM7G36.USD","BK4588","LU1057294990.SGD","SG9999001176.SGD","LU0861579265.USD","LU0912757837.SGD","LU1935042991.SGD","BK4568","LU1196500208.SGD","LU1093756168.USD","LU2750360997.AUD","LU0965508806.USD","LU2324357040.USD","LU2133065610.SGD","LU2129689514.USD","IE00B3PB1722.GBP","MRK","LU2471134523.USD","LU1116320901.HKD","LU0965509010.AUD","LU1914381329.SGD","LU2471134796.USD","SG9999014575.USD","IE00B3T34201.USD","LU2505996509.AUD","IE00BLSP4239.USD","LU0006306889.USD","LU1066051811.HKD","SG9999014559.SGD","LU1037948541.HKD","LU0787776722.HKD","LU1093756325.SGD","BK4516","SGXZ57979304.SGD","LU1718418525.SGD","IE00BBT3K403.USD","LU0889566641.SGD","IE0034235303.USD","LU1066051498.USD","IE000M9KFDE8.USD","LU0211331839.USD","LU0238689110.USD","LU0098860793.USD","IE00B4R5TH58.HKD","LU0965509283.SGD","IE00BKVL7J92.USD","LU1032955483.USD","IE00B19Z3B42.SGD","BK4007","IE00BN8TJ469.HKD","LU0124676726.USD","LU2361045086.USD","LU1280957306.USD","LU1917777945.USD","LU2430703095.HKD","LU2602419157.SGD","LU2750360641.GBP","LU1291159041.SGD","LU0689626769.HKD","LU1496350502.SGD","BK4504","BK4533","LU2347655156.SGD","IE00BLSP4452.SGD","BK4581","LU1261432733.SGD","LU2592432038.USD","BK4534","BK4592","IE00BVYPNW00.USD","BK4550","IE00BJT1NW94.SGD","LU0058720904.USD","IE00B2B36J28.USD","LU2112291526.USD","LU2023250843.SGD","LU1894683264.USD","LU0122379950.USD","LU1221951046.USD","LU0882574055.USD","LU2471134952.CNY","IE00B19Z3581.USD","LU0345769128.USD","SG9999014567.USD","SG9999014542.SGD","LU1201861249.SGD","LU0345770993.USD","LU0130102774.USD","LU1989772923.USD","LU2430703251.USD","IE00BGHQF631.EUR"],"gpt_icon":0},{"id":"2614238967","title":"Pfizer initiated with an Underperform at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2614238967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614238967?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:13","pubTimestamp":1771967608,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Trung Huynh initiated coverage of Pfizer (PFE) with an Underperform rating and $25 price target Published first on TheFly – the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pfizer-initiated-with-an-underperform-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pfizer-initiated-with-an-underperform-at-rbc-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0170899867.USD","IE00B19Z3B42.SGD","LU1066051498.USD","LU0868494617.USD","SG9999013999.USD","LU0985481810.HKD","BK4207","LU0029864427.USD","BK4581","BK4007","BK4550","LU1894683348.USD","IE00BLSP4239.USD","SG9999002224.SGD","IE00BLSP4452.SGD","BK4588","LU0122379950.USD","IE0002270589.USD","LU0708994859.HKD","LU0225284248.USD","SG9999001176.USD","SGXZ57979304.SGD","BK4599","BK4568","BK4585","LU0234572021.USD","LU1023059063.AUD","LU1894683264.USD","IE00BBT3K403.USD","BK4592","IE000M9KFDE8.USD","BK4533","LU1267930573.SGD","SG9999001176.SGD","IE00B19Z3581.USD","LU0321505439.SGD","LU0456855351.SGD","LU0306806265.USD","LU1066053197.SGD","SG9999002232.USD","LU0225771236.USD","LU1057294990.SGD","LU1883839398.USD","PFE","LU0321505868.SGD","LU0289739699.SGD","LU0058720904.USD","SG9999011175.SGD","LU0306807586.USD","SG9999003800.SGD","BK4534","LU0310800379.SGD","LU0128525929.USD"],"gpt_icon":0},{"id":"2614740678","title":"Vir Biotechnology Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2614740678","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614740678?lang=en_us&edition=fundamental","pubTime":"2026-02-25 05:05","pubTimestamp":1771967101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nTUA5XW3FT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4568","BK4139","VIR","BK4535"],"gpt_icon":0},{"id":"2614747282","title":"Pfizer Gets Full FDA Approval for Braftovi Combination for Colon Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2614747282","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614747282?lang=en_us&edition=fundamental","pubTime":"2026-02-25 04:40","pubTimestamp":1771965605,"startTime":"0","endTime":"0","summary":"Pfizer  received full approval from the US Food and Drug Administration for its drug Braftovi in combination with Erbitux and fluorouracil-based chemotherapy for the treatment of adults with BRAF V600E-mutated metastatic colorectal cancer.The conversion from accelerated approval was based on \"significant benefit in outcomes\" for both progression-free survival and overall survival in a Phase 3 study, Pfizer said Tuesday in a statement.The Braftovi combination is under regulatory review in Europe and has been approved in several other countries, Pfizer said.Eli Lilly  manufactures and commercializes Erbitux in North America.Pfizer shares rose 0.3% in Tuesday trading, and Lilly fell 1.4%.Price: 27.15, Change: +0.09, Percent Change: +0.34","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443382.USD","LU1548497426.USD","LU1983299246.USD","IE00BJJMRY28.SGD","LU0964807845.USD","LU2089984988.USD","LU2471134796.USD","LU2271345857.HKD","SG9999015986.USD","LU2756315318.SGD","BK4568","LU2237443622.USD","SG9999001176.SGD","LU0823434740.USD","LU0006306889.USD","IE00B2B36J28.USD","LU2471134523.USD","LU0385154629.USD","LU0820562030.AUD","LU0225283273.USD","LU0289739699.SGD","ELIS","LU0114720955.EUR","LU0823434583.USD","LU1057294990.SGD","BK4592","LU0234572021.USD","LU0320765059.SGD","LU0889565916.HKD","LU1814569148.SGD","LLYX","LU2211815571.USD","IE00BLSP4452.SGD","LU2491050154.USD","LU2087625088.SGD","BK4550","IE00BFSS8Q28.SGD","IE00BK4W5M84.HKD","IE00BFTCPJ56.SGD","LU0109391861.USD","LU1023059063.AUD","LU2357305700.SGD","LU2462157665.USD","LU1868837300.USD","LU2750360641.GBP","LU0079474960.USD","SG9999001176.USD","SG9999015952.SGD","LU2112291526.USD","SG9999014906.USD","BK4588","LU0122379950.USD","LU2023250504.SGD","LU2896262040.SGD","LU0097036916.USD","SG9999018865.SGD","LU0094547139.USD","LU0868494617.USD","IE00BJT1NW94.SGD","LU0225771236.USD","LU1804176565.USD","LU0882574139.USD","LU0943347566.SGD","LU1720051017.SGD","LU1883839398.USD","IE00BFSS7M15.SGD","LU2168564149.EUR","IE00BJJMRX11.SGD","IE0004445015.USD","LU1551013425.SGD","SG9999002232.USD","IE00BJLML261.HKD","SG9999018857.SGD","IE0002270589.USD","LU1629891620.HKD","LU1623119135.USD","LU2491049909.HKD","LU1093756168.USD","LU2213496289.HKD","LU2237438978.USD","LU2361045086.USD","LU2602419157.SGD","SG9999014898.SGD","LU1989771016.USD","BK4581","LU0323591593.USD","LU2456880835.USD","SG9999013999.USD","LU1894683264.USD","LU1069344957.HKD","LU0823416689.USD","LU1280957306.USD","LU1988902786.USD","LU2750360997.AUD","SG9999015978.USD","LU0203202063.USD","LU0353189763.USD","LU0708995401.HKD","LU1145028129.USD","LU2552382215.SGD","LU2106854487.HKD","LU0256863811.USD","LU2237443978.SGD","LU2552382132.HKD","LU2471134879.HKD","LU0882574055.USD","IE00B1XK9C88.USD","SG9999014880.SGD","LU2237443465.HKD","LU2264538146.SGD","LU0238689110.USD","PFE","BK4533","IE0005OL40V9.USD","IE00B19Z3B42.SGD","LU0985481810.HKD","LU2756315664.SGD","IE00B1BXHZ80.USD","LU0306807586.USD","LU0321505868.SGD","LU0432979614.USD","LU0225284248.USD","IE0001KFT4U8.USD","LU0640476718.USD","IE0002141913.USD","LU0158827948.USD","LU0170899867.USD","LU0471298694.HKD","LU0672654240.SGD","BK7095","LU1720051108.HKD","IE00B7KXQ091.USD","IE00BJJMRZ35.SGD","LU0198837287.USD","LU2028103732.USD","LU2023251221.USD","LU0061475181.USD","LU0266013472.USD","LU2552382058.USD","LU1064131342.USD","IE00BKPKM429.USD","SG9999017495.SGD","LU2063271972.USD","SGXZ31699556.SGD","IE00BN29S564.USD","IE00BK4W5L77.USD","LU2111349929.HKD","LU2746668974.SGD","LU1551013342.USD","LU0058720904.USD","LU0466842654.USD","LU2265009873.SGD","LU2089284900.SGD","LU2468319806.SGD","LU0820561909.HKD","SGXZ57979304.SGD","BK4534","LU1894683348.USD","SG9999011175.SGD","LU1291159041.SGD","LU1868837136.USD","LU1066051498.USD","LU0354030511.USD","LU0256863902.USD","BK4599","LU0106261372.USD","IE00BBT3K403.USD","LU0456855351.SGD","LU0787776722.HKD","LU2168564065.EUR","IE0004445239.USD","LU0417517546.SGD","IE00B775H168.HKD","LU2417539215.USD","LU1061106388.HKD","BK4516","LU1366192091.USD","LU0689472784.USD","LU2491050071.SGD","LU2023250330.USD","SG9999003800.SGD","SGXZ81514606.USD","LU1917777945.USD","IE0009355771.USD","LU2461242641.AUD","BK4007","LU0109394709.USD","LU2237443549.SGD","IE00BLSP4239.USD","IE00B4R5TH58.HKD","LU0316494557.USD","LU2360106947.USD","LU2108987350.USD","LU1712237335.SGD","LU1868836757.USD","SG9999015945.SGD","LLII","LU2236285917.USD","LU0820561818.USD","LU1323610961.USD","LU2361044949.HKD","LU1066053197.SGD","LU2746668461.USD","LU0210536198.USD","ELIL","LU1868836914.USD","IE00B19Z3581.USD","LU2168563687.JPY","GB00BDT5M118.USD","LU0786609619.USD","LU2361044865.SGD","LU0158827781.USD","IE00B4JS1V06.HKD","LU2237443895.HKD","LU1232071149.USD","LLYZ","LU0096364046.USD","LU0321505439.SGD","LU2168564222.USD","LU1267930730.SGD","LU2324357040.USD","LU0306806265.USD","IE00BKDWB100.SGD","LU2089283258.USD","LU0683600562.USD","LU2471134952.CNY","LU0471298777.SGD","LU1127390331.HKD","LU1974910355.USD","IE000M9KFDE8.USD","SGXZ99366536.SGD","LU1035775433.USD","BK4585","LU0353189680.USD","LU2168564495.EUR","LU0320765992.SGD","LU1093756325.SGD","LU1868836591.USD","SG9999014914.USD","SGXZ51526630.SGD","IE00BWXC8680.SGD","SG9999002224.SGD","LU0354030438.USD","LU0203201768.USD"],"gpt_icon":0},{"id":"2614725321","title":"Wrongful Death Case Tests Abbott’s FreeStyle Libre 3 Risk Oversight","url":"https://stock-news.laohu8.com/highlight/detail?id=2614725321","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614725321?lang=en_us&edition=fundamental","pubTime":"2026-02-25 04:31","pubTimestamp":1771965080,"startTime":"0","endTime":"0","summary":"A wrongful death lawsuit has been filed alleging defects in Abbott Laboratories' FreeStyle Libre 3 and Libre 3 Plus glucose monitors.\nThe complaint links the devices to multiple deaths and serious injuries worldwide.\nThe legal action follows a medical device correction and prior FDA serious safety alerts related to these continuous glucose monitoring systems.\n\nAbbott Laboratories (NYSE:ABT) is a major player in medical devices, including continuous glucose monitoring products that are widely...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/247483-main-header/1756216816685"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/wrongful-death-case-tests-abbotts-freestyle-libre-3-risk-ove","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-abt/abbott-laboratories/news/wrongful-death-case-tests-abbotts-freestyle-libre-3-risk-ove","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0170899867.USD","LU1061106388.HKD","LU2133065610.SGD","LU0868494617.USD","LU0266013472.USD","LU2089984988.USD","IE0009355771.USD","BK4581","LU1721429402.USD","SG9999002224.SGD","SGXZ41872573.SGD","LU2324357040.USD","BK4588","LU0122379950.USD","LU1989763690.USD","LU0114720955.EUR","SGXZ23171101.USD","LU1691799644.USD","LU2468319806.SGD","LU0882574055.USD","BK4568","BK4585","LU0234572021.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU1721429741.USD","LU2112291526.USD","BK4592","BK4533","IE0002141913.USD","SG9999004303.SGD","LU1989763427.SGD","SG9999002232.USD","BK4566","LU1057294990.SGD","BK4082","BK4504","LU2211815571.USD","ABT","LU0058720904.USD","LU2237957811.SGD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","LU1914381329.SGD","LU2237957902.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2614533742","title":"U.S. FDA Grants Full Approval to Pfizer’s Braftovi Combination Regimen in First-Line Metastatic Colorectal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2614533742","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614533742?lang=en_us&edition=fundamental","pubTime":"2026-02-25 03:30","pubTimestamp":1771961400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nTUA9MBLRB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0002270589.USD","SG9999001176.USD","BK4568","SG9999002232.USD","BK4534","LU0868494617.USD","LU1057294990.SGD","LU1894683264.USD","LU0321505868.SGD","BK4599","LU0225284248.USD","PFE","SG9999001176.SGD","LU0122379950.USD","BK4588","IE00BLSP4452.SGD","SG9999013999.USD","LU0058720904.USD","IE00B19Z3581.USD","BK4533","LU0289739699.SGD","LU1023059063.AUD","BK4550","LU0321505439.SGD","IE00B19Z3B42.SGD","BK4585","SG9999011175.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0170899867.USD","BK4007","LU1883839398.USD","LU1066053197.SGD","LU0985481810.HKD","BK4592","LU1894683348.USD","LU0234572021.USD","LU0306806265.USD","IE00BLSP4239.USD","SG9999002224.SGD","BK4581","SG9999003800.SGD","LU0306807586.USD","LU1066051498.USD","LU0456855351.SGD","IE000M9KFDE8.USD","LU0225771236.USD"],"gpt_icon":0},{"id":"2614744334","title":"BRIEF-FDA Grants Traditional Approval To Encorafenib For Metastatic Colorectal Cancer With Braf V600e Mutation","url":"https://stock-news.laohu8.com/highlight/detail?id=2614744334","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614744334?lang=en_us&edition=fundamental","pubTime":"2026-02-25 02:28","pubTimestamp":1771957727,"startTime":"0","endTime":"0","summary":"BRIEF-FDA Grants Traditional Approval To Encorafenib For Metastatic Colorectal Cancer With Braf V600e MutationFeb 24  - FDA:FDA: GRANTS TRADITIONAL APPROVAL TO ENCORAFENIB FOR METASTATIC COLORECTAL CANCER WITH A BRAF V600E MUTATIONFurther company coverage: PFE.N ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nFWN3ZK1EL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU0985481810.HKD","LU1023059063.AUD","SG9999001176.SGD","LU1894683264.USD","BK4581","LU1894683348.USD","LU1066051498.USD","IE00BLSP4452.SGD","SG9999011175.SGD","LU0122379950.USD","SG9999002224.SGD","SG9999001176.USD","LU0170899867.USD","SG9999003800.SGD","BK4585","BK4533","SGXZ57979304.SGD","IE00B19Z3B42.SGD","SG9999002232.USD","BK4599","LU0456855351.SGD","SG9999013999.USD","BK4568","LU0321505439.SGD","IE00BLSP4239.USD","BK4588","LU0234572021.USD","LU0868494617.USD","LU0306806265.USD","BK4007","LU0225771236.USD","IE0002270589.USD","LU0225284248.USD","LU0321505868.SGD","BK4534","PFE","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0306807586.USD","BK4550","LU1066053197.SGD","IE00BBT3K403.USD","BK4592","LU1883839398.USD","LU0058720904.USD","LU1057294990.SGD"],"gpt_icon":0},{"id":"2614419137","title":"FDA: Grants Traditional Approval to Encorafenib for Metastatic Colorectal Cancer With a Braf V600e Mutation","url":"https://stock-news.laohu8.com/highlight/detail?id=2614419137","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614419137?lang=en_us&edition=fundamental","pubTime":"2026-02-25 01:56","pubTimestamp":1771955798,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nFWN3ZK1EL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0321505439.SGD","LU1894683348.USD","BK4599","LU0289739699.SGD","LU0170899867.USD","BK4581","BK4007","IE00BBT3K403.USD","BK4533","LU0234572021.USD","LU0985481810.HKD","BK4588","SG9999003800.SGD","BK4592","IE00BLSP4452.SGD","SG9999001176.SGD","LU0456855351.SGD","LU0225771236.USD","LU0122379950.USD","LU1066051498.USD","LU1023059063.AUD","PFE","LU0058720904.USD","LU1894683264.USD","SG9999002224.SGD","LU1883839398.USD","LU0868494617.USD","IE00B19Z3581.USD","LU1057294990.SGD","BK4550","LU0225284248.USD","SGXZ57979304.SGD","LU1066053197.SGD","BK4585","IE00B19Z3B42.SGD","SG9999013999.USD","SG9999002232.USD","IE000M9KFDE8.USD","BK4568","LU0306807586.USD","LU0306806265.USD","BK4534","LU0321505868.SGD","SG9999001176.USD","IE0002270589.USD","IE00BLSP4239.USD","SG9999011175.SGD"],"gpt_icon":0},{"id":"2613743110","title":"Vir Biotechnology Up Nearly 34%, on Pace for Largest Percent Increase Since January 2025 -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2613743110","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613743110?lang=en_us&edition=fundamental","pubTime":"2026-02-24 23:39","pubTimestamp":1771947540,"startTime":"0","endTime":"0","summary":"Vir Biotechnology, Inc.  is currently at $9.94, up $2.51 or 33.81%. --Would be highest close since Feb. 6, 2025, when it closed at $10.23. --On pace for largest percent increase since Jan. 8, 2025, when it rose 58.17%. --Down 88.03% from its all-time closing high of $83.07 on Jan. 27, 2021. --Up 9.25% from 52 weeks ago , when it closed at $9.10. --Traded as high as $10.29; highest intraday level since Feb. 7, 2025, when it hit $10.65. --Up 38.49% at today's intraday high; largest intraday percent increase since Jan. 8, 2025, when it rose as much as 83.14%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VIR","BK4535","BK4568","BK4585","BK4139"],"gpt_icon":0},{"id":"2613912743","title":"Class Action Lawsuit Targets Lakeland Industries Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2613912743","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613912743?lang=en_us&edition=fundamental","pubTime":"2026-02-24 23:34","pubTimestamp":1771947262,"startTime":"0","endTime":"0","summary":"A securities class action lawsuit has been filed in the U.S. District Court for the Southern District of New York against Lakeland Industries Inc. on behalf of investors who bought the company’s securities between Dec. 1, 2023 and Dec. 9, 2025. The complaint alleges the company failed to disclose operational problems in its Pacific Helmets and Jolly businesses and other headwinds that allegedly made its financial guidance and public statements misleading. Investors have until April 24, 2026 to seek appointment as lead plaintiff.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260224:nNDL2CzMkt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014005.SGD","IE00B64PRP62.GBP","BK4112","IE00B66KJ199.SGD","NDAQ","IE00BKPKM429.USD","LU0314104364.USD","BK4202","LU2095319765.USD","LAKE","IE0031619046.USD","IE00BGHQF748.EUR","BK4585","IE00B7SZL793.SGD","IE00B19Z4B17.USD","SG9999014021.USD","BK4588","SG9999014013.SGD","BK4568","SG9999014039.USD","LU2210149790.SGD","LU2210150020.SGD"],"gpt_icon":0},{"id":"2613107417","title":"Vir Biotechnology price target raised to $18 from $14 at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2613107417","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613107417?lang=en_us&edition=fundamental","pubTime":"2026-02-24 22:37","pubTimestamp":1771943842,"startTime":"0","endTime":"0","summary":"Needham raised the firm’s price target on Vir Biotechnology (VIR) to $18 from $14 and keeps a Buy rating on the shares. Along with its better than ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vir-biotechnology-price-target-raised-to-18-from-14-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vir-biotechnology-price-target-raised-to-18-from-14-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","VIR","BK4139","BK4585","BK4535"],"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":1,"totalSize":384,"code":"91000000","status":"200"}]}}